Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 121 AL 135

[How to Proceed with Diagnosing Memory Loss]

Ikeda M.

Brain Nerve. 2026 Sep;78(9):1003-1014. doi: 10.11477/mf.188160960780091003.

Right Temporal Variant Frontotemporal Dementia Presenting With Prosopagnosia: Insights From 18 F-FDG PET and MRI

Baltacioglu MH, Oguz PS, Erdol MS.

Clin Nucl Med. 2026 Sep 1;51(9):e787-e788. doi: 10.1097/RLU.0000000000006430. Epub 2026 Mar 19.

Alzheimer's disease and related dementias in South and Southeast Asia: a systematic review and meta-analysis of epidemiology and associated factors

Rahman M, Saha T, Nayeem MAJ, Tabassum A, Abdullah I, Sultana S, Jahan I, Hasan I, Hayat S, Papri N, Mohammad QD, Islam Z.

BMJ Open. 2026 Sep 23;16(9):e118140. doi: 10.1136/bmjopen-2026-118140.

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker

Paranhos T, Katsumi Y, Brickhouse MJ, Eloyan A, Eckbo R, Zaitsev A, Du A, La Joie R, Thangarajah M, Taurone A, Vemuri P, Jack CR; as the LEADS Consortium; Hammers DB, Aisen PS, Beckett LA, Koeppe R, Kukull WA, Toga AW, Atri A, Clark DG, Day GS, Duara R, Graff-Radford NR, Grant IM, Honig LS, Johnson E, Jones DT, Masdeu JC, Mendez MF, Musiek ES, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo T, Wolk DA, Womack KB, Carrillo MC, Rabinovici GD, Apostolova LG, Dickerson BC, Eldaief MC, Touroutoglou A.

Neurology. 2026 Oct 13;107(7):e218519. doi: 10.1212/WNL.0000000000218519. Epub 2026 Aug 26.

Neuropsychiatric symptoms as early clinical indicators and functional biomarkers of cognitive decline in mild cognitive impairment and early Alzheimer's disease

de Levante Raphael D.

J Alzheimers Dis. 2026 Sep;113(1):5-15. doi: 10.1177/13872877261469114. Epub 2026 Jul 27.

Head-to-head comparison of plasma biomarker assays across platforms for amyloid pathology in a multicenter cohort

Lv X, Shen K, Zhao Q, Peng G, Liu H, Gao F, Pan X, Chen W, Lu P, Zhang H, Zhang S, Xing M, Chen Q, Wang Y, Cheng Z, Wang Y, Zeng S, Xie F, Pan Y, Shen Y, Chen X, Shi J.

Sci Bull (Beijing). 2026 Sep 15;71(17):4506-4515. doi: 10.1016/j.scib.2026.08.018. Epub 2026 Aug 5.

Chronic kidney disease and cognitive decline: choroid plexus remodeling, glymphatic dysfunction, and alzheimer biomarker interpretation

Corrêa LMA, Oliveira da Silva R, Brandão LKV, Delmiro Silva YR, da Silva ÉVB, Tretow J, Gomes EDC, Fernandes CCS, Moreira GNCM, Zanella J.

Neurol Sci. 2026 Sep 11;47(10):774. doi: 10.1007/s10072-026-09362-0.

Diagnostic value of blood p-tau subtypes in Alzheimer's disease progression and pathology: systematic review and meta-analysis

Zhang P, Huang D, Lu X, Zhong H, Liu C, Liu H, Duan X, Wu J.

Eur Arch Psychiatry Clin Neurosci. 2026 Oct;276(7):3329-3341. doi: 10.1007/s00406-026-02353-4. Epub 2026 Aug 22.

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes

Hey JA, Abushakra S, Power A, Watson D, Porsteinsson A, Sabbagh M, MacSweeney E, Cohen S, Boada M, Doraiswamy PM, Elahi FM, Rissman RA, Liang E, Flint S, Hristova E, Kesslak P, McLaine R, Albayrak A, Schaefer JF, Yu JY, Tolar L, Tolar M.

Drugs. 2026 Oct;86(10):1705-1721. doi: 10.1007/s40265-026-02381-3. Epub 2026 Sep 1.

Nation-wide Japanese FTD consortium FTLD-J: Utility of case review meetings

Sato S, Mori K, Masuda M, Suzuki M, Taomoto D, Takasaki A, Shigenobu K, Ouma S, Shinagawa S, Kobayashi R, Watanabe Y, Takeda A, Miyagawa Y, Kawanami A, Tsunoda N, Hara K, Hotta M, Hidaka Y, Yoshiyama K, Kowa H, Katsuno M, Tsujino A, Ikeuchi T, Yabe I, Nakamura M, Tanaka F, Kawakatsu S, Arai T, Yokota O, Izumi Y, Yoshida M, Hashimoto M, Watanabe H, Sobue G, Ikeda M; FTLD-J Study researchers.

Int Psychogeriatr. 2026 Jun;38(3):100078. doi: 10.1016/j.inpsyc.2025.100078. Epub 2025 Apr 30.

Kynurenine pathway dysregulation in cognitive impairment and dementia: a systematic review and meta-analysis

Choe K, Bakker L, van den Hove DLA, Eussen SJPM, Kenis G, Ramakers IHGB, Verhey FRJ, Rutten BPF, Köhler S.

Geroscience. 2026 Jun;48(3):4585-4619. doi: 10.1007/s11357-025-01636-3. Epub 2025 May 8.

Dietary Patterns and Risk of Dementia in Elderly Individuals: A Systematic Review and Meta-analysis of Cohort Studies

Wang Y, Lin X, Cheng L, Cheng X, He J, Xia S.

Nutr Rev. 2026 Jun 1;84(6):1111-1128. doi: 10.1093/nutrit/nuaf121.

Cognitive Engagement and Dementia Risk: A Dose-Response Comparison of Nursing Home and Community Residents

Lee J, Kim J.

J Appl Gerontol. 2026 Aug;45(8):1520-1529. doi: 10.1177/07334648251386106. Epub 2025 Oct 9.

Social determinants of health associated with neuropsychiatric symptoms of dementia and mild cognitive impairment: A narrative review

Shin J, Tampi R, Joshi P, Jester DJ, Jeste DV.

Int Psychogeriatr. 2026 Aug;38(4):100152. doi: 10.1016/j.inpsyc.2025.100152. Epub 2025 Oct 15.

Long-term dementia risk following electroconvulsive therapy: A GRADE-assessed systematic review and meta-analysis

Kassar O, Makhlouf HA, Mansour MEM, Sartorius A.

Int Psychogeriatr. 2026 Jun;38(3):100159. doi: 10.1016/j.inpsyc.2025.100159. Epub 2025 Oct 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias